Keywords | Page numbers |
Adenocarcinoma |
169 |
Anaplastic lymphoma kinase |
173 |
Angioleiomyoma |
126 |
Biobank |
93 |
Bronchial carcinoid tumor |
159 |
Carcinoid variants |
159 |
Core needle biopsy |
173 |
Cutaneous |
126 |
Developmental cysts |
169 |
Duodenum |
109 |
Endoscopic mucosal resection |
109 |
Endoscopic resection |
109 |
Endoscopic submucosal dissection |
109 |
Fine needle aspiration cytology |
142 |
Gastrointestinal stromal tumours |
116 |
Hepatitis B |
154 |
Histopathology |
109, 154 |
Human tissue biobank |
93 |
Immunohistochemistry |
173 |
Inflammatory myofibroblastic tumor |
173 |
KIT |
116 |
Leiomyosarcoma |
126 |
Liquid-based cervical cytology |
135 |
Lung |
173 |
Lymphoma |
164 |
Manual method |
135 |
Milan System for Reporting Salivary Gland Cytology |
142 |
Morphology |
116 |
Osseous metaplasia |
159 |
PD-L1 |
164 |
PDGFRA |
116 |
Pathology-centered biobank |
93 |
Piloleiomyoma |
126 |
Quality control |
93 |
Risk of malignancy |
142 |
Risk of neoplasm |
142 |
Salivary glands |
142 |
Sequence analysis |
116 |
Smooth muscle tumor |
126 |
Spontaneous neoplasm regression |
164 |
Sustainability |
93 |
Tailgut cysts |
169 |
Tenofovir |
154 |
ThinPrep Imaging System |
135 |
Thyroid neoplasms |
164 |